Daniela Paňková
Co-Founder & Chief Executive Officer Terasom
Daniela Pankova is a biotech entrepreneur and cancer research scientist, best known as the co-founder and CEO of Terasom. She has a background in oncology, cell biology, and translational medicine, with research experience at the University of Oxford. Daniela focuses on advancing exosome-based therapeutics, cancer diagnostics, and regenerative medicine technologies. She also works closely with academic and clinical partners to bridge scientific innovation with real-world healthcare applications.
Seminars
Thursday 24th September 2026
Translating Exosome Based Diagnostics from Discovery to Clinical Use to Overcome Challenges in Standardisation & Validation
3:30 pm
- Addressing pre-analytical and analytical variability in exosome isolation, quantification, and characterization workflows
- Establishing robust validation frameworks to ensure reproducibility and clinical reliability across patient populations
- Navigating regulatory pathways for adoption of exosome-based diagnostic assays in clinical laboratories
